From ₹397 to ₹1,081: This largecap pharma stock surges 170% in 10 months
The homegrown pharma company has outperformed the BSE Sensex and Healthcare index in terms of returns in the last one year.
The homegrown pharma company has outperformed the BSE Sensex and Healthcare index in terms of returns in the last one year.
The scrip opened higher at ₹1,014.95, up 0.73%, as against the previous closing price of ₹1,007.50